NM-IL-12 (rHuIL-12)

recombinant human interleukin-12 · Neumedicines Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NM-IL-12 (rHuIL-12), covering 2016-08-03 to 2018-11-16. Get the full timeline:

Most recent: Clinical Trial Update: NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds [Phase 2]